This is the authors' abstract. We don't add key points for this paper.
The importance of providing structural validity evidence for test score(s) derived from psychometric test instruments is highlighted by several institutions; for example, the American Psychological Association (2014) demands that evidence for the validity of an instruments' internal structure and its underlying measurement model must be provided before it is applied in psychological assessment.The knowledge about the latent structure of data obtained with tests addressing the major question "What is/are the construct[s] being measured" by psychological tests under investigation (Ziegler, 2014(Ziegler, , 2020)).The study of structural validity is typically addressed with factor analyses when the test scores reflect continuous latent traits.As most submissions to Psychological Test Adaptation and Development (PTAD) deal with the adaptation and further development of existing measures, authors typically test a measurement model that is based on theoretical considerations and prior findings on original versions (or adaptations) of the test under investigation.Our literature review of PTAD's publications showed that more than 90% of the articles contain at least one confirmatory factor analysis (CFA).As editor and reviewers of PTAD, we appreciate that authors are rigorous in providing evidence on the structural validity of their tests' data.However, since PTAD's inception in 2019, we experience that one comment is frequently communicated to authors during the review process, namely, the request to adjust the analytic approach in CFA from maximum likelihood (ML) estimation toward using the mean-and variance-adjusted weighted least squares (WLSMV; Muthn et al., 1997) estimator to account for the ordinal nature of the data that psychological instruments typically generate on the item level.In this editorial, we discuss the rationale behind choosing the WLSMV estimator when analyzing test adaptations and developments that are based on ordinal categorical data and concisely illustrate the problems associated with using the ML estimator (potentially in combination with robust tests of model fit) for such data.
No takes yet. Share an insight, caveat, or question.
Brauer et al. (2023) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: